J.P. Morgan discloses dealings in Kangji Medical Holdings privatization

On October 27, 2025, the Securities and Futures Commission (SFC) released a public disclosure form detailing dealings in Kangji Medical Holdings Limited shares, part of a privatization effort via a scheme of arrangement. J.P. Morgan Securities PLC, identified as a Class (5) associate connected with the offeror, disclosed its transactions.

The dealings, made for J.P. Morgan Securities PLC's own account, involved the closing out of two derivative contracts on October 24, 2025. One contract involved 2,000 reference securities, with a total amount paid/received of $17,963.4000. The other involved 1,000 reference securities, totaling $8,981.7000. Both contracts had a maturity/closing out date of September 24, 2027.

Following these transactions, J.P. Morgan Securities PLC's resultant balance stood at 10,414,843 and 10,413,843 respectively for the two dealings. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.